Cite
MLA Citation
GR Foster et al.. “PTH-137 Safety and efficacy of simeprevir (SMV) plus PEG-IFN/RBV in treatment-naÏve chronic hepatitis c genotype 1 patients eligible for 12 weeks of treatment.” Gut, vol. 64, n.d., pp. A468–A469. http://access.bl.uk/ark:/81055/vdc_100137792043.0x00004a